Clinical Trials Directory

Trials / Unknown

UnknownNCT02990767

Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Shanghai First Maternity and Infant Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The aims of this study are to develop algorithms based on a combination of maternal factors, uterine artery PI, MAP and serum biomarkers to estimate patient-specific risks for early Preeclampsia (PE) and to evaluate the screening performance of such algorithms in twins.

Detailed description

Preeclampsia (PE) is still a leading cause of fetal and maternal morbidity and mortality with an incidence of 3-5% worldwide. Despite intensive research efforts the pathogenesis of the disease is still unknown but it is likely to be multifactorial.Clinical risk factors traditionally have been used to identify women at high risk of developing preeclampsia,and biophysical factors that may help predict hypertensive disorders of pregnancy.In addition,changes in the serum concentrations of angiogenic and antiangiogenic factors are implied in the pathogenesis of PE and have possible relevance in the diagnosis of the disease.

Conditions

Timeline

Start date
2016-06-01
Primary completion
2017-06-01
Completion
2019-06-01
First posted
2016-12-13
Last updated
2016-12-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02990767. Inclusion in this directory is not an endorsement.